{"addison's disease": 8.87, "administration site extravasation": 9.1, "adrenal disorder": 44.02, "adrenal insufficiency": 55.54, "adrenocortical insufficiency acute": 16.24, "adrenocorticotropic hormone deficiency": 80.27, "adverse event": 18.86, "alanine aminotransferase abnormal": 2.79, "altered state of consciousness": 2.02, "amylase increased": 5.29, "aortic arteriosclerosis": 2.83, "aortitis": 3.7, "ascites": 2.61, "aspartate aminotransferase abnormal": 4.51, "atelectasis": 3.27, "atrioventricular block complete": 4.1, "autoimmune arthritis": 23.13, "autoimmune colitis": 26.54, "autoimmune haemolytic anaemia": 6.46, "autoimmune hepatitis": 13.93, "autoimmune hypothyroidism": 38.07, "autoimmune lung disease": 35.99, "autoimmune myocarditis": 52.65, "autoimmune myositis": 19.69, "autoimmune nephritis": 27.84, "autoimmune pancreatitis": 32.49, "autoimmune thyroiditis": 6.96, "bladder tamponade": 8.28, "blood albumin decreased": 2.73, "blood alkaline phosphatase abnormal": 5.81, "blood bilirubin abnormal": 3.37, "blood corticotrophin decreased": 41.84, "blood corticotrophin increased": 36.22, "blood creatine phosphokinase increased": 2.73, "blood creatine phosphokinase mb increased": 2.32, "blood creatinine abnormal": 3.41, "blood creatinine decreased": 2.54, "blood sodium decreased": 3.06, "blood thyroid stimulating hormone abnormal": 9.81, "blood thyroid stimulating hormone decreased": 11.98, "blood thyroid stimulating hormone increased": 15.88, "brain natriuretic peptide increased": 2.55, "brain oedema": 3.04, "c-reactive protein increased": 2.81, "cachexia": 2.0, "cancer pain": 9.3, "cancer surgery": 12.47, "capillary leak syndrome": 2.19, "carbohydrate antigen 125 increased": 2.71, "carcinoembryonic antigen increased": 3.86, "cardiac dysfunction": 3.43, "cardiac failure acute": 2.62, "cardiac tamponade": 9.15, "cardiomyopathy": 2.18, "cardiotoxicity": 2.31, "central hypothyroidism": 4.54, "central venous catheterisation": 6.16, "cheilitis": 2.54, "chemotherapy": 7.47, "cholangitis": 12.99, "cholangitis sclerosing": 62.95, "cholecystitis": 5.89, "cholecystitis acute": 5.37, "cholestasis": 2.44, "cholestatic liver injury": 3.86, "chronic gastritis": 2.6, "colitis": 14.86, "colitis microscopic": 5.24, "computerised tomogram abnormal": 2.26, "coronavirus infection": 2.6, "cortisol abnormal": 32.35, "cortisol decreased": 26.42, "cortisol increased": 10.51, "cutaneous sarcoidosis": 4.49, "cutaneous symptom": 4.08, "cytokine storm": 10.87, "cytomegalovirus enterocolitis": 5.55, "cytopenia": 2.09, "death": 3.26, "decreased activity": 2.02, "decreased appetite": 2.35, "demyelinating polyneuropathy": 2.01, "dermatitis": 2.7, "dermatitis bullous": 2.64, "dermatitis exfoliative": 2.2, "dermatitis psoriasiform": 7.57, "dermatomyositis": 8.46, "device related infection": 2.24, "diabetes insipidus": 2.5, "diabetes mellitus": 2.46, "diabetic ketoacidosis": 3.23, "disseminated intravascular coagulation": 4.67, "drug effective for unapproved indication": 5.34, "drug eruption": 4.9, "drug-induced liver injury": 4.36, "duodenal perforation": 6.54, "duodenal ulcer": 3.21, "duodenitis": 3.28, "dysphonia": 4.51, "eastern cooperative oncology group performance status worsened": 47.08, "electrolyte imbalance": 3.15, "emphysema": 2.74, "encephalitis": 10.23, "encephalitis autoimmune": 15.03, "endocrine disorder": 12.34, "enteritis": 4.81, "enteritis infectious": 4.09, "enterocolitis": 17.21, "enterocolitis haemorrhagic": 3.22, "eosinophil count increased": 4.69, "eosinophil percentage increased": 7.98, "eosinophilia": 2.26, "eosinophilic fasciitis": 11.96, "erythema multiforme": 6.8, "exfoliative rash": 2.1, "eyelid ptosis": 7.19, "febrile bone marrow aplasia": 3.44, "febrile neutropenia": 2.38, "feeding disorder": 2.42, "female genital tract fistula": 12.84, "fistula": 3.61, "fulminant type 1 diabetes mellitus": 91.12, "gallbladder enlargement": 3.0, "gastric perforation": 2.92, "gastrointestinal oedema": 4.77, "gastrointestinal perforation": 8.13, "glomerulonephritis membranous": 3.01, "glomerulonephritis rapidly progressive": 5.67, "glossitis": 2.26, "glucocorticoid deficiency": 24.57, "guillain-barre syndrome": 2.13, "haemoglobin abnormal": 3.72, "haemophagocytic lymphohistiocytosis": 8.03, "hepatic cyst": 2.13, "hepatic cytolysis": 3.53, "hepatic failure": 2.3, "hepatic function abnormal": 7.14, "hepatitis": 10.13, "hepatitis acute": 2.49, "hepatitis fulminant": 4.65, "hepatotoxicity": 2.57, "hospice care": 10.07, "hydronephrosis": 4.54, "hyperamylasaemia": 5.17, "hypercalcaemia": 3.03, "hyperlipasaemia": 3.82, "hypersensitivity pneumonitis": 2.28, "hypertension": 3.83, "hyperthyroidism": 25.85, "hypertransaminasaemia": 2.53, "hypoalbuminaemia": 3.59, "hypocalcaemia": 2.21, "hypokalaemia": 2.11, "hyponatraemia": 3.66, "hypophysitis": 26.38, "hypopituitarism": 43.93, "hypothalamo-pituitary disorder": 44.55, "hypothyroidism": 38.18, "ileus": 4.17, "ileus paralytic": 2.2, "ill-defined disorder": 3.55, "immune thrombocytopenia": 4.64, "immune-mediated adrenal insufficiency": 181.06, "immune-mediated adverse reaction": 75.19, "immune-mediated arthritis": 90.69, "immune-mediated cholangitis": 229.86, "immune-mediated cystitis": 50.92, "immune-mediated dermatitis": 58.9, "immune-mediated encephalitis": 68.44, "immune-mediated endocrinopathy": 65.15, "immune-mediated enterocolitis": 92.49, "immune-mediated gastritis": 72.0, "immune-mediated hepatic disorder": 140.64, "immune-mediated hepatitis": 55.12, "immune-mediated hyperthyroidism": 222.07, "immune-mediated hypophysitis": 26.37, "immune-mediated hypothyroidism": 289.34, "immune-mediated lung disease": 65.14, "immune-mediated myasthenia gravis": 109.09, "immune-mediated myocarditis": 72.42, "immune-mediated myositis": 76.82, "immune-mediated nephritis": 55.26, "immune-mediated neurological disorder": 52.92, "immune-mediated neuropathy": 25.15, "immune-mediated pancreatitis": 112.35, "immune-mediated pancytopenia": 49.03, "immune-mediated pericarditis": 68.35, "immune-mediated renal disorder": 166.28, "immune-mediated thyroiditis": 40.65, "immune-mediated uveitis": 89.29, "inability to afford medication": 3.43, "inappropriate antidiuretic hormone secretion": 4.48, "inappropriate schedule of product administration": 2.96, "infectious pleural effusion": 5.44, "infusion related reaction": 2.53, "infusion site extravasation": 2.64, "interstitial lung disease": 21.24, "intestinal fistula": 7.45, "intestinal perforation": 4.76, "intra-abdominal fluid collection": 3.7, "keratitis": 2.34, "kl-6 increased": 25.94, "large intestine perforation": 4.24, "leukoderma": 22.05, "lichen planus": 7.6, "lichenoid keratosis": 15.2, "lipase increased": 2.28, "liver abscess": 2.31, "liver disorder": 4.44, "lung abscess": 3.99, "lung carcinoma cell type unspecified recurrent": 7.45, "lung consolidation": 2.66, "lung disorder": 4.48, "lung opacity": 7.7, "lymphadenectomy": 13.05, "lymphadenopathy mediastinal": 4.08, "lymphangiosis carcinomatosa": 16.28, "lymphocytic hypophysitis": 12.91, "malignant ascites": 14.29, "malignant neoplasm progression": 28.82, "malignant pleural effusion": 14.55, "mastectomy": 5.22, "melanoma recurrent": 20.81, "meningitis": 4.84, "meningitis aseptic": 2.55, "metastases to meninges": 2.85, "metastatic malignant melanoma": 2.26, "mixed liver injury": 3.75, "mucosal disorder": 2.54, "mucosal inflammation": 2.62, "myasthenia gravis": 24.48, "myasthenia gravis crisis": 7.23, "myasthenic syndrome": 18.14, "myelosuppression": 2.21, "myocardial necrosis marker increased": 2.88, "myocarditis": 4.01, "myopathy": 2.74, "myositis": 19.63, "nephritis": 32.56, "nephropathy toxic": 2.44, "nephrotic syndrome": 2.94, "neuromyopathy": 3.88, "neuropathy peripheral": 2.82, "neutrophil count decreased": 3.04, "non-small cell lung cancer recurrent": 15.85, "nutritional condition abnormal": 6.38, "ocular myasthenia": 9.45, "oesophageal stenosis": 4.24, "oesophagitis": 2.12, "onychomadesis": 2.22, "ophthalmoplegia": 3.06, "optic neuritis": 2.97, "oral mucosa erosion": 6.2, "organising pneumonia": 17.01, "oxygen saturation abnormal": 2.97, "oxygen therapy": 6.52, "palliative care": 8.33, "palmar-plantar erythrodysaesthesia syndrome": 8.34, "pancreatic enzymes increased": 2.62, "pancreatic failure": 4.72, "paraneoplastic syndrome": 10.64, "pemphigoid": 14.66, "pericardial effusion": 3.05, "pericarditis malignant": 70.25, "peripheral sensory neuropathy": 2.02, "peritonitis": 2.32, "physical deconditioning": 2.97, "platelet count decreased": 4.37, "pleural effusion": 3.41, "pneumatosis intestinalis": 4.36, "pneumocystis jirovecii pneumonia": 3.54, "pneumonia": 2.52, "pneumonia aspiration": 4.48, "pneumonia bacterial": 8.84, "pneumonitis": 19.78, "pneumothorax": 4.76, "polyarthritis": 6.02, "polymyalgia rheumatica": 4.64, "polymyositis": 9.96, "posterior reversible encephalopathy syndrome": 2.22, "postrenal failure": 12.62, "prerenal failure": 6.54, "primary adrenal insufficiency": 18.79, "primary hypothyroidism": 13.0, "procalcitonin increased": 3.73, "product use in unapproved indication": 10.22, "product use issue": 4.16, "protein urine": 15.04, "protein urine present": 3.53, "proteinuria": 12.87, "pulmonary sarcoidosis": 7.2, "pulmonary toxicity": 13.71, "pulmonary tuberculosis": 2.0, "pyelonephritis": 2.51, "radiation pneumonitis": 24.69, "radiotherapy": 19.86, "rash maculo-papular": 2.1, "recurrent cancer": 8.55, "red blood cell transfusion": 4.03, "renal disorder": 2.16, "renal impairment": 3.94, "renal tubular acidosis": 3.29, "respiratory failure": 2.44, "retroperitoneal fibrosis": 10.39, "rhabdomyolysis": 2.16, "salivary hyposecretion": 4.64, "sarcoidosis": 4.33, "secondary adrenocortical insufficiency": 33.04, "septic shock": 2.64, "seronegative arthritis": 4.51, "sialoadenitis": 6.23, "silent thyroiditis": 46.59, "sjogren's syndrome": 6.77, "skin disorder": 3.61, "skin erosion": 2.94, "skin toxicity": 6.08, "small intestinal haemorrhage": 3.08, "small intestinal perforation": 17.23, "stevens-johnson syndrome": 8.17, "stomatitis": 4.71, "stress cardiomyopathy": 4.47, "superior vena cava syndrome": 5.82, "systemic inflammatory response syndrome": 2.13, "terminal state": 2.07, "therapeutic response increased": 10.66, "therapy partial responder": 13.55, "thrombophlebitis migrans": 35.9, "thyroid disorder": 14.39, "thyroid function test abnormal": 7.49, "thyroid hormones decreased": 11.22, "thyroid hormones increased": 8.97, "thyroiditis": 37.4, "thyrotoxic crisis": 12.27, "thyroxine free decreased": 6.63, "thyroxine free increased": 10.77, "toxic epidermal necrolysis": 7.47, "toxic skin eruption": 2.0, "transfusion": 2.43, "tri-iodothyronine free decreased": 14.68, "tri-iodothyronine free increased": 28.34, "troponin i increased": 2.82, "troponin increased": 4.16, "troponin t increased": 3.52, "tubulointerstitial nephritis": 17.11, "tumour associated fever": 48.73, "tumour haemorrhage": 6.31, "tumour hyperprogression": 68.27, "tumour lysis syndrome": 2.58, "tumour marker increased": 3.44, "tumour necrosis": 14.76, "tumour pain": 7.01, "tumour pseudoprogression": 64.34, "type 1 diabetes mellitus": 33.16, "type 2 diabetes mellitus": 2.19, "uveitis": 3.73, "vitiligo": 17.33, "vocal cord paralysis": 2.64, "vogt-koyanagi-harada disease": 7.51, "warm autoimmune haemolytic anaemia": 11.46}